These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 72111

  • 1. Functional differentiation of B lymphocytes in congenital agammaglobulinemia. II. Immunochemical analysis of the in vitro primary immune response.
    Percy ME, Dosch HM, Gelfand EW.
    J Immunol; 1977 Dec; 119(6):1965-72. PubMed ID: 72111
    [Abstract] [Full Text] [Related]

  • 2. Functional differentiation of B lymphocytes in congenital agammaglobulinemia. I. Generation of hemolytic plaque-forming cells.
    Dosch HM, Percy ME, Gelfand EW.
    J Immunol; 1977 Dec; 119(6):1959-64. PubMed ID: 334978
    [Abstract] [Full Text] [Related]

  • 3. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S, Kubagawa H, Cooper MD.
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [Abstract] [Full Text] [Related]

  • 4. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT, Naides SJ, Benacerraf B, Sy MS.
    J Mol Cell Immunol; 1985 Jul; 2(2):107-17. PubMed ID: 2978459
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis.
    Abdou NI, Casella SR, Abdou NL, Abrahamsohn IA.
    J Clin Invest; 1973 Sep; 52(9):2218-24. PubMed ID: 4580388
    [Abstract] [Full Text] [Related]

  • 6. Lymphoid cell lines from patients with "non-secretory" agammaglobulinemia produce glycosylated heavy chains which are reduced in molecular weight.
    Schwaber J, Rosen FS.
    J Mol Cell Immunol; 1984 Sep; 1(5):279-91. PubMed ID: 6443854
    [Abstract] [Full Text] [Related]

  • 7. Analysis of surface mu-chain expression in human lymphoblastoid cell lines that do not produce light chains.
    Hendershot L, Levitt D.
    J Immunol; 1984 Jan; 132(1):502-9. PubMed ID: 6418805
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
    Pastorelli G, Roncarolo MG, Touraine JL, Rousset F, Pene J, de Vries JE.
    Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
    [Abstract] [Full Text] [Related]

  • 9. Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.
    Dosch H-M, Gelfand EW.
    J Immunol; 1977 Jan; 118(1):302-8. PubMed ID: 401513
    [Abstract] [Full Text] [Related]

  • 10. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T, Leiserson WM, Asofsky R.
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
    Nossal GJ, Pike BL, Battye FL.
    Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
    [Abstract] [Full Text] [Related]

  • 12. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
    DeHeer DH, Edgington TS.
    J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
    [Abstract] [Full Text] [Related]

  • 13. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
    Stockdale AM, Dul JL, Wiest DL, Digel M, Argon Y.
    J Immunol; 1987 Nov 15; 139(10):3527-35. PubMed ID: 3500220
    [Abstract] [Full Text] [Related]

  • 14. Ig biosynthesis in a human pre-B cell line.
    McCune JM, Fu SM.
    J Immunol; 1981 Dec 15; 127(6):2609-11. PubMed ID: 6271874
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H, Berzofsky JA.
    J Immunol; 1986 Jan 15; 136(1):58-65. PubMed ID: 3079611
    [Abstract] [Full Text] [Related]

  • 16. Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM.
    Thiele CJ, Stevens RH.
    J Immunol; 1980 Apr 15; 124(4):1898-904. PubMed ID: 6767777
    [Abstract] [Full Text] [Related]

  • 17. Abnormal immunoglobulins in severe combined immunodeficiency: analysis by immunoelectrophoresis and SDS-polyacrylamide gel electrophoresis.
    Wardlow ML, Hariman F, Criswell BS, South MA, De Fazio SR.
    Exp Hematol; 1979 Mar 15; 7(3):151-61. PubMed ID: 109303
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin secretion by human splenic lymphocytes in vitro: the effects of antibodies to IgM and IgD.
    Finkelman FD, Lipsky PE.
    J Immunol; 1978 May 15; 120(5):1465-72. PubMed ID: 96179
    [Abstract] [Full Text] [Related]

  • 19. In vitro immune response of human peripheral lymphocytes. VII. Effect of anti-mu and anti-delta antibodies on B colony formation and detection of abnormal B cells in patients with juvenile rheumatoid arthritis.
    Muraguchi A, Kishimoto T, Kuritani T, Yamamura Y.
    J Immunol; 1980 Dec 15; 125(6):2638-42. PubMed ID: 6776196
    [Abstract] [Full Text] [Related]

  • 20. Triggering of human peripheral blood B cells: polyclonal induction and modulation of an in vitro PFC response.
    Friedman SM, Breard JM, Chess L.
    J Immunol; 1976 Nov 15; 117(5 Pt.2):2021-8. PubMed ID: 792335
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.